ReproUnion
Reproductive Medicine Across Borders
Challenge 1
Improvement of
Human Male Fertility
Challenge 2
Optimizing Medically Assisted Reproductive Treatment
Challenge 3
Securing Female Ovarian Function
Challenge 4
Prevention of
Infertility-related Morbidity
Challenge 5
Fertility Awareness
Challenge 1
Improvement of Human Male Fertility
Challenge 2
Optimizing Medically Assisted Reproductive Treatment
Challenge 3
Securing Female Ovarian Function
Challenge 4
Prevention of Infertility-related Morbidity
Challenge 5
Fertility Awareness
When asking young people, most envision a life with children, but reproductive challenges affect up to 25% of couples in Scandinavia. Every 8th woman never becomes a mother, and every 5th man never becomes a father.
With a new research and innovation paradigm within reproductive medicine in the Øresund Region, ReproUnion wants to meet current and future demands of preventing, managing, and treating infertility. Infertility is recognized as a disease by the WHO, but despite revolutionary developments in the techniques for assisted reproduction, the success rate is still below 30%.
ReproUnion drives fertility collaboration across borders and disciplines between academia, hospitals, and industry. Our aim is to understand the underlying reasons of infertility and to personalise and improve fertility treatment. We also work on preventive initiatives to ensure that the society and young people are equipped with the right information to make informed choices about family planning.
Below you can watch the film about ReproUnion: A decade of Reproductive Health Collaboration
News
Find out what’s going on & stay up to date
Anja Pinborg calls for careful interpretation of a US study suggesting pregnancy complications are more likely after ART
The study associates assisted reproduction with an increased risk of complications during pregnancy, especially in women aged 35 years or older and those with pre-existing health problems. However, participants in the study were pooled into one group, not distinguishing between different fertility treatments and the techniques used nor between singletons and twin births.
ReproUnion supported PhD provides novel insights on the molecular changes provoked by short-term testosterone deficiency
Barbara Sahlin has successfully defended her PhD and a key outcome of the study is the identification of three candidate protein markers of androgen activity, which she hopes can be a tool to better determine testosterone deficiency. Testosterone is crucial for reproductive function.
New RMC facilities will benefit fertility patients and reproductive research
On the 14th of December 2021 Reproduktionsmedicinsk centrum (RMC) in Malmö opened the doors to their new top-modern facilities. With more operating and consultation rooms up to twice as many fertility patients can be treated and the new facilities also support ReproUnion research activities.
